Tribute to Professor Raphael Mechoulam, The Founder of Cannabinoid and Endocannabinoid Research
Acknowledgments
Conflicts of Interest
References
- Elsohly, M.A.; Slade, D. Chemical constituents of marijuana: The complex mixture of natural cannabinoids. Life Sci. 2005, 78, 539–548. [Google Scholar] [CrossRef] [PubMed]
- Maccarrone, M. Missing pieces to the endocannabinoid puzzle. Trends Mol. Med. 2020, 26, 263–272. [Google Scholar] [CrossRef] [PubMed]
- Gaoni, Y.; Mechoulam, R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 1964, 86, 1646–1647. [Google Scholar] [CrossRef]
- Devane, W.A.; Hanus, L.; Breuer, A.; Pertwee, R.G.; Stevenson, L.A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258, 1946–1949. [Google Scholar] [CrossRef] [PubMed]
- Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.; Kaminski, N.E.; Schatz, A.R.; Gopher, A.; Almog, S.; Martin, B.R.; Compton, D.R.; et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995, 50, 83–90. [Google Scholar] [CrossRef]
- Sugiura, T.; Kondo, S.; Sukagawa, A.; Nakane, S.; Shinoda, A.; Itoh, K.; Yamashita, A.; Waku, K. 2-Arachidonoylgylcerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 1995, 215, 89–97. [Google Scholar] [CrossRef] [PubMed]
- Mechoulam, R.; Hanuš, L.O.; Pertwee, R.; Howlett, A.C. Early phytocannabinoid chemistry to endocannabinoids and beyond. Nat. Rev. Neurosci. 2014, 15, 757–764. [Google Scholar] [CrossRef] [PubMed]
- Pacher, P.; Kogan, N.M.; Mechoulam, R. Beyond THC and endocannabinoids. Annu. Rev. Pharmacol. Toxicol. 2020, 60, 637–659. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kogan, N.M.; Lavi, Y.; Topping, L.M.; Williams, R.O.; McCann, F.E.; Yekhtin, Z.; Feldmann, M.; Gallily, R.; Mechoulam, R. Novel CBG derivatives can reduce inflammation, pain and obesity. Molecules 2021, 26, 5601. [Google Scholar] [CrossRef] [PubMed]
- Howlett, A.C.; Thomas, B.F.; Huffman, J.W. The spicy story of cannabimimetic indoles. Molecules 2021, 26, 6190. [Google Scholar] [CrossRef] [PubMed]
- Santos-Molina, L.; Herrerias, A.; Zawatsky, C.N.; Gunduz-Cinar, O.; Cinar, R.; Iyer, M.R.; Wood, C.M.; Lin, Y.; Gao, B.; Kunos, G.; et al. Effects of a peripherally restricted hybrid inhibitor of CB1 receptors and iNOS on alcohol drinking behavior and alcohol-induced endotoxemia. Molecules 2021, 26, 5089. [Google Scholar] [CrossRef] [PubMed]
- Shen, M.; Manca, C.; Suriano, F.; Nallabelli, N.; Pechereau, F.; Al-lam-Ndoul, B.; Iannotti, F.A.; Flamand, N.; Veilleux, A.; Cani, P.D.; et al. Three of a kind: Control of the expression of liver-expressed antimicrobial peptide 2 (LEAP2) by the endocannabinoidome and the gut microbiome. Molecules 2022, 27, 1. [Google Scholar] [CrossRef]
- Straiker, A.; Wilson, S.; Corey, W.; Dvorakova, M.; Bosquez, T.; Tracey, J.; Wilkowski, C.; Ho, K.; Wager-Miller, J.; Mackie, K. An evaluation of understudied phytocannabinoids and their effects in two neuronal models. Molecules 2021, 26, 5352. [Google Scholar] [CrossRef] [PubMed]
- Stollenwerk, T.M.; Pollock, S.; Hillard, C.J. Contribution of the adenosine 2A receptor to behavioral effects of tetrahydrocannabinol, cannabidiol and PECS-101. Molecules 2021, 26, 5354. [Google Scholar] [CrossRef] [PubMed]
- Saumell-Esnaola, M.; Barrondo, S.; Caño, G.G.d.; Aranzazu Goicolea, M.; Sallés, J.; Lutz, B.; Monory, K. Subsynaptic distribution, lipid raft targeting and G protein-dependent signaling of the type 1 cannabinoid receptor in synaptosomes from the mouse hippocampus and frontal cortex. Molecules 2021, 26, 6897. [Google Scholar] [CrossRef] [PubMed]
- Bari, M.; Battista, N.; Fezza, F.; Finazzi-Agrò, A.; Maccarrone, M. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J. Biol. Chem. 2005, 280, 12212–12220. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Leo, L.M.; Abood, M.E. CB1 cannabinoid receptor signaling and biased signaling. Molecules 2021, 26, 5413. [Google Scholar] [CrossRef] [PubMed]
- Komorowska-Müller, J.A.; Rana, T.; Olabiyi, B.F.; Zimmer, A.; Schmöle, A.-C. Cannabinoid receptor 2 alters social memory and microglial activity in an age-dependent manner. Molecules 2021, 26, 5984. [Google Scholar] [CrossRef] [PubMed]
- Guo, Y.; Uyama, T.; Rahman, S.M.K.; Sikder, M.M.; Hussain, Z.; Tsuboi, K.; Miyake, M.; Ueda, N. Involvement of the γ isoform of cPLA2 in the biosynthesis of bioactive N-acylethanolamines. Molecules 2021, 26, 5213. [Google Scholar] [CrossRef] [PubMed]
- Burgaz, S.; García, C.; Gonzalo-Consuegra, C.; Gómez-Almería, M.; Ruiz-Pino, F.; Unciti, J.D.; Gómez-Cañas, M.; Alcalde, J.; Morales, P.; Jagerovic, N.; et al. Preclinical investigation in neuroprotective effects of the 2 GPR55 ligand VCE-006.1 in experimental models of Parkin-3 son’s disease and amyotrophic lateral sclerosis. Molecules 2021, 26, 7643. [Google Scholar] [CrossRef] [PubMed]
Time Range | Cannabinoids and Disease | Endocannabinoids and Disease |
---|---|---|
1964–1970 | 0 | - |
1971–1975 | 14 | - |
1976–1980 | 19 | - |
1981–1985 | 18 | - |
1986–1990 | 23 | - |
1991–1995 | 37 | 0 |
1996–2000 | 103 | 16 |
2001–2005 | 497 | 178 |
2006–2010 | 1305 | 665 |
2011–2015 | 1608 | 884 |
2016–2021 | 2924 | 1580 |
Mechoulam Award Recipient | Year |
---|---|
Allyn Howlett | 2000 |
Billy Martin | 2001 |
Roger Pertwee | 2002 |
Raj Razdan | 2003 |
Murielle Rinaldi-Carmona and Francis Barth | 2004 |
George Kunos | 2005 |
John Huffman and Alex Makriyannis | 2006 |
Vincenzo Di Marzo | 2007 |
Ken Mackie | 2008 |
Gerard Le Fur | 2009 |
Patti Reggio | 2010 |
Cecilia Hillard | 2011 |
Ben Cravatt | 2012 |
Aron Lichtman | 2013 |
Beat Lutz | 2014 |
Mary Abood | 2015 |
Mauro Maccarrone | 2016 |
Daniele Piomelli | 2017 |
Andreas Zimmer | 2018 |
Daniela Parolaro | 2019 |
Natsuo Ueda | 2020 |
Javier Fernandez-Ruiz | 2021 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Maccarrone, M. Tribute to Professor Raphael Mechoulam, The Founder of Cannabinoid and Endocannabinoid Research. Molecules 2022, 27, 323. https://doi.org/10.3390/molecules27010323
Maccarrone M. Tribute to Professor Raphael Mechoulam, The Founder of Cannabinoid and Endocannabinoid Research. Molecules. 2022; 27(1):323. https://doi.org/10.3390/molecules27010323
Chicago/Turabian StyleMaccarrone, Mauro. 2022. "Tribute to Professor Raphael Mechoulam, The Founder of Cannabinoid and Endocannabinoid Research" Molecules 27, no. 1: 323. https://doi.org/10.3390/molecules27010323
APA StyleMaccarrone, M. (2022). Tribute to Professor Raphael Mechoulam, The Founder of Cannabinoid and Endocannabinoid Research. Molecules, 27(1), 323. https://doi.org/10.3390/molecules27010323